Attached files

file filename
EX-3.1 - EX-3.1 - IsoPlexis Corpexhibit31-sx1a1.htm
EX-3.2 - EX-3.2 - IsoPlexis Corpexhibit32-sx1a1.htm
EX-10.15 - EX-10.15 - IsoPlexis Corpexhibit1015-sx1a1.htm
S-1/A - S-1/A - IsoPlexis Corpisoplexis-sx1a1.htm
EX-10.10 - EX-10.10 - IsoPlexis Corpexhibit1010-sx1a1.htm
EX-10.14 - EX-10.14 - IsoPlexis Corpexhibit1014-sx1a1.htm
EX-10.11 - EX-10.11 - IsoPlexis Corpexhibit1011-sx1a1.htm
EX-10.13 - EX-10.13 - IsoPlexis Corpexhibit1013-sx1a1.htm
EX-10.18 - EX-10.18 - IsoPlexis Corpexhibit1018-sx1a1.htm
EX-10.12 - EX-10.12 - IsoPlexis Corpexhibit1012s-1a1.htm
EX-4.2 - EX-4.2 - IsoPlexis Corpexhibit42-sx1a1.htm
EX-4.1 - EX-4.1 - IsoPlexis Corpexhibit41-sx1a1.htm
EX-10.16 - EX-10.16 - IsoPlexis Corpexhibit1016-sx1a1.htm
EX-10.17 - EX-10.17 - IsoPlexis Corpexhibit1017-sx1a1.htm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement No. 333-258046 on Form S-1 of our report dated May 13, 2021 relating to the financial statements of IsoPlexis Corporation. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

Hartford, Connecticut

August 20, 2021